Aerovate Therapeutics, Inc. (AVTE) Return On Assets % [USD] 2022 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aerovate Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2022 to 2024.
  • Aerovate Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2024 was -61.9 %, a 52.6% decline year-over-year.
  • Aerovate Therapeutics, Inc. annual Return On Assets for 2023 was -55.1 %, a 61.9% decline from 2022.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -61.9 -21.4 -52.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -55.1 -21.1 -61.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -50.4 -22.7 -82.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -45.6 -23.7 -108% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.6 -19.5 -92.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -34 Oct 1, 2022 Dec 31, 2022
Q3 2022 -27.7 Jul 1, 2022 Sep 30, 2022
Q2 2022 -21.9 Apr 1, 2022 Jun 30, 2022
Q1 2022 -21.1 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.